← FDA DRUG APPROVALS

FDA ANDA · ANDA075480

ENALAPRIL MALEATE

Sponsor: AUROBINDO PHARMA USA

APPLICATION
ANDA075480
TYPE
ANDA
ORIGINAL APPROVAL
2000-08-22
LATEST ACTION
2016-04-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ENALAPRIL MALEATEDiscontinued
ENALAPRIL MALEATE 10MG · TABLET · ORAL
ENALAPRIL MALEATEDiscontinued
ENALAPRIL MALEATE 2.5MG · TABLET · ORAL
ENALAPRIL MALEATEDiscontinued
ENALAPRIL MALEATE 20MG · TABLET · ORAL
ENALAPRIL MALEATEDiscontinued
ENALAPRIL MALEATE 5MG · TABLET · ORAL

Approval history

2016-04-18Labeling · Supplement 14 · standardAP
2016-04-18Labeling · Supplement 15 · standardAP
2015-01-23Labeling · Supplement 13 · standardAP
2011-05-30Manufacturing (CMC) · Supplement 10AP
2002-12-19Labeling · Supplement 1AP
2000-08-22OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →